COMPARISON OF INTRALESIONAL SCLEROTHRERAPY WITH BLEOMYCIN VS SODIUM TETRA DECYL SULPHATE IN LYMPHANGIOMA

Author:

Bisht Janki1,Prasad Akshay2

Affiliation:

1. Associate Professor Dept of Pediatric surgery NRS Medical college ,Kolkata

2. Post doctoral trainee Dept of Pediatric surgery NRS Medical college ,Kolkata

Abstract

The purpose of this study is to compare between the efficacy of Bleomycin and Sodium tetra decyl sulphate as intralesional sclerotherapy for lymphangioma. Materials and methods- This prospective study was done between Jan 2018 to Jan 2020. Total of 30 patients with lymphatic malformations at head neck, axilla, chest wall and lower limb were included. Group I was given intralesional injection of bleomycin and Group II was injected with STS. All the cases were evaluated for a minimum period of one and a maximum of 2 years. Result Efficacy of bleomycin was found to be superior to STS, when used as intralesional sclerotherapic agent. Most of the vascular lesions of group I resolved after first dose giving excellent response in 60% as compared to 40% in STS group. Conclusion Intralesional bleomycin and sodium tetradecyl sulphate are safe and effective sclerosing agents in lymphangiomas of children, but bleomycin is more effective in reducing the size of the lesions.

Publisher

World Wide Journals

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3